Skip to main content
. Author manuscript; available in PMC: 2023 Feb 1.
Published in final edited form as: Gastroenterology. 2021 Oct 30;162(2):415–430. doi: 10.1053/j.gastro.2021.10.036

Figure 3: The divergent effects of Ras activation in isthmal progenitor cells and chief cells establish two types of pyloric metaplasia.

Figure 3:

Increases in Ras activation in isthmal progenitor cells in transgenic mice and in the setting of Ménétrier’s disease leads to massive foveolar hyperplasia (foveolar hyperplasia predominant pyloric metaplasia, FHP-PM) with preferential differentiation of foveolar cells, and to a lesser extent mucous neck cells, over parietal cells. In contrast, activation of Ras in chief cells leads initially to the development of SPEM from reprogramming of chief cells (SPEM-associated pyloric metaplasia, SA-PM). Continuously active Ras expression can lead to intestinal metaplasia and dysplasia, establishing the full range of pre-neoplastic lineages associated with the development of intestinal type gastric cancer. Note: the intestinal metaplasia depicted here would be of the “incomplete type.” The figure is not meant to show definitively which exact cells are the ones fueling the expansion of dysplastic/neoplastic cells, but evidence does point to lineages at the interface of intestinal metaplasia arising from pyloric metaplasia/SPEM as the figure depicts.